CGEM vs LOW · $830.3M cap vs P/E 18, rev $86.29B
Cullinan Oncology LLC (CGEM) versus Lowe's Companies Inc (LOW) — a side-by-side from cached financials, not a winner call.
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
Latest reported LOW revenue for 2026-01-30 was $86.29B. Net income was $6.65B. Revenue was up 3.1% from 2025-01-31 to 2026-01-30. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
CGEM currently screens at market cap $830.3M. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Not investment advice. Open the CGEM and LOW stock pages for the full models.
Not investment advice.